Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Novartis Builds $23B North Carolina Manufacturing Hub, Adding 700 Jobs
Company

Novartis Builds $23B North Carolina Manufacturing Hub, Adding 700 Jobs

November 20, 2025
Lynk's LNK01004 Pan-JAK Inhibitor Shows EASI-75 Win in Phase 2 Atopic Dermatitis Trial
CompanyDrug

Lynk’s LNK01004 Pan-JAK Inhibitor Shows EASI-75 Win in Phase 2 Atopic Dermatitis Trial

November 20, 2025
Acotec's Jingyi Balloon Catheter Wins NMPA Approval for Complex Coronary Lesions
CompanyMedical Device

Acotec’s Jingyi Balloon Catheter Wins NMPA Approval for Complex Coronary Lesions

November 19, 2025
Sino Biopharm's LM-350 CDH17-ADC Wins NMPA Nod for Clinical Trials
CompanyDrug

Sino Biopharm’s LM-350 CDH17-ADC Wins NMPA Nod for Clinical Trials

November 19, 2025
Cutia's CU-40105 Topical Finasteride Spray NDA Accepted by NMPA, a China First
CompanyDrug

Cutia’s CU-40105 Topical Finasteride Spray NDA Accepted by NMPA, a China First

November 19, 2025
Mirxes and Walvax Form RNA Partnership for Vaccines and Precision Medicine
CompanyDeals

Mirxes and Walvax Form RNA Partnership for Vaccines and Precision Medicine

November 19, 2025
NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications
Policy / Regulatory

NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications

November 19, 2025
Roche's Lunsumio SC Wins EU Conditional Approval for Follicular Lymphoma
CompanyDrug

Roche’s Lunsumio SC Wins EU Conditional Approval for Follicular Lymphoma

November 19, 2025
Roche's giredestrant SERD Achieves iDFS Win in Phase 3 lidERA Breast Cancer Trial
CompanyDrug

Roche’s giredestrant SERD Achieves iDFS Win in Phase 3 lidERA Breast Cancer Trial

November 19, 2025
Hengrui's HRS-6209 CDK4 Inhibitor Wins NMPA Nod for Breast Cancer Combo Trial
CompanyDrug

Hengrui’s HRS-6209 CDK4 Inhibitor Wins NMPA Nod for Breast Cancer Combo Trial

November 18, 2025
Gate Bioscience Closes $65M Series B to Advance Molecular Gates to Clinic
CompanyDeals

Gate Bioscience Closes $65M Series B to Advance Molecular Gates to Clinic

November 18, 2025
Hengrui's HRS-4642 KRAS G12D Inhibitor Wins NMPA Nod for Phase 1b/2 Solid Tumor Trials
CompanyDrug

Hengrui’s HRS-4642 KRAS G12D Inhibitor Wins NMPA Nod for Phase 1b/2 Solid Tumor Trials

November 18, 2025
1 2 … 23 24 25 26 27 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up